Tag: letrozole

Letrozole: Trade name Femara. Letrozole is an aromatase inhibitor used to treat ER+ breast cancer. Aromatase inhibitors are designed to inhibit the action of the enzyme aromatase, which converts androgens into estrogens within the body.

Articles

News

09/08/13
Not completing anti-estrogen treatment linked to sharply higher risk of recurrence
04/30/13
Unpleasant side effects of anti-estrogens can indicate treatment is working
12/31/12
Treatment with Femara after tamoxifen can worsen cholesterol profile
07/19/12
Aromatase inhibitors are less effective in reducing estrogen in women with high BMI
07/15/12
Reduction in breast density shows endocrine treatment is working
09/07/11
Strongly estrogen positive lobular breast cancer responds well to neoadjuvant Femara
07/17/11
Increasingly severe side effects of aromatase inhibitors may make tamoxifen first the best strategy
03/01/11
Aromatase inhibitor only or after tamoxifen are both effective treatments
06/12/10
Cognitive function improves after completion of both Femara and tamoxifen treatment
03/07/10
Weight gain can increase hot flashes in breast cancer survivors on aromatase inhibitors
02/13/10
Tamoxifen treatment results in cognitive impairment compared to Aromasin
01/22/10
Treatment with aromatase inhibitors results in better breast cancer outcomes than tamoxifen

Studies




Breast cancer resources | Definitions | Selected supplements and vitamins | Privacy policy | Search | Tags | Disclaimer/about us | Make a donation | Sitemap